Non-nucleotide Small Molecules: diABZI: Intravenous administration of the novel small-molecule STING agonist diABZI (a linked amidobenzimidazole derivative) elicited strong anti-tumor activity in immunocompetent mice with established syngeneic colon tumors, resulting in complete and lasting regression of tumors (101). Here, STING1 is linked to neoplasm.